Applied Molecular Evolution's P2P Acquisition

Applied Molecular Evolution raised a round of funding on November 22, 2003. Investors include Eli Lilly & Co..

Applied Molecular Evolution (AME) is a leader in applying directed molecular evolution to improve healthcare by discovering, optimizing and developing human biotherapeutics. Since its inception, AME's…

Articles about Applied Molecular Evolution's P2P Acquisition: